Subscribe To
Why is femasys (femy) stock up 181% today?
Femasys (NASDAQ: FEMY ) stock is rocketing higher on Tuesday following approval from the Food and Drug Administration (FDA) for FemaSeed. FemaSeed is...
September 26, 2023, 8:04 am
Femasys inc. receives u.s. fda clearance to market femaseed, an innovative infertility treatment solution
– The 510(k) Clearance from the United States Food and Drug Administration (FDA) allows for the U.S. commercialization of FemaSeed®, an intratubal ...
September 25, 2023, 9:25 pm
Invo bioscience to report fourth quarter and fiscal year 2022 financial results on monday, april 17, 2023
INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced ...
April 11, 2023, 5:30 pm
In-vitro fertilization (ivf) devices market is predicted to surge ahead at an impressive cagr of 19% by the end of 2033
Rapidly Rising infertility Cases in Men & Women Augmenting Demand for IVF Devices. The rising adoption ...
February 6, 2023, 5:30 pm
infertility market size worth usd 3,650 million by 2030 at 12.8% cagr – report by market research future (mrfr)
infertility Market Trends and Insights By Sex (Males, Females And Unexplained), By Diagnosis (Men Diagn...
December 15, 2022, 12:30 am
Progyny: solving infertility problem
Progyny is a leading benefit management company that specializes in fertility and family building. Their revenue has been growing at an amazing pace (...
July 5, 2022, 1:35 pm
Progyny stock: a hidden gem tackling infertility
Progyny is a hidden gem tackling a prevalent and growing issue. With massive growth ahead and a solid competitive position, Progyny is a great additio...
May 31, 2022, 1:26 pm